F.G.A. van der Meché

2.2k citations

27 papers · 1.6k indexed · h-index 14

Neurology top 1%
- Peripheral Neuropathies and Disorders 21
- Long-Term Effects of COVID-19 4
- Autoimmune Neurological Disorders and Treatments 2
Cellular and Molecular Neuroscience top 5%
- Hereditary Neurological Disorders 12
- Nerve injury and regeneration 3
Pathology and Forensic Medicine top 5%
- Multiple Sclerosis Research Studies 2
Immunology
Neurology top 10%
- Peripheral Neuropathies and Disorders 21
- Long-Term Effects of COVID-19 4
- Autoimmune Neurological Disorders and Treatments 2
Cardiology and Cardiovascular Medicine
- Takotsubo Cardiomyopathy and Associated Phenomena 2
Physiology
- Pain Mechanisms and Treatments 2

Co-authors: Jan Meulstee P.A. van Doorn Rogier Q. Hintzen R. P. Kleyweg Pieter A. van Doorn F.G.I. Jennekens A. Cecile J.W. Janssens Josien B. de Boer
Cited by: Neurology Cellular and Molecular Neuroscience Pathology and Forensic Medicine
Journals: Neurology (7 papers)Clinical Neurology and Neurosurgery (3 papers)The Journal of Infectious Diseases (2 papers)
Partner nations: Netherlands Slovakia Germany

In The Last Decade

F.G.A. van der Meché

27 papers receiving 1.5k citations

Peers

Countries citing papers authored by F.G.A. van der Meché

Since Specialization

Citations

This map shows the geographic impact of F.G.A. van der Meché's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.G.A. van der Meché with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.G.A. van der Meché more than expected).

Fields of papers citing papers by F.G.A. van der Meché

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.G.A. van der Meché. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.G.A. van der Meché. The network helps show where F.G.A. van der Meché may publish in the future.

Co-authorship network

The 25 scholars most cited alongside F.G.A. van der Meché, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with F.G.A. van der Meché Line = papers co-authored together F.G.A. van der Meché links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Psychosocial dysfunction in the first year after Guillain–Barré syndrome Muscle & Nerve ·L Zhang,A.E.J. de Jager,Wietske Kuijer‐Siebelink,F.G.A. van der Meché,Theo P. B. M. Suurmeijer	2009	24
2	Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners Acta Neurologica Scandinavica ·A. Cecile J.W. Janssens,P.A. van Doorn,Josien B. de Boer,F.G.A. van der Meché,Jan Passchier,Rogier Q. Hintzen	2003	234
3	Prospective study on the relationship between infections and multiple sclerosis exacerbations Brain ·D. Buljevac,H. Zwenneke Flach,Wim C.J. Hop,Daniëlle Hijdra,Jon D. Laman,H.F.J. Savelkoul,F.G.A. van der Meché,P.A. van Doorn,Rogier Q. Hintzen	2002	327
4	Quality of life complements traditional outcome measures in immune-mediated polyneuropathies Neurology ·Ingemar S.J. Merkies,Paul Schmitz,F.G.A. van der Meché,Johnny P.A. Samijn,Pieter A. van Doorn	2002	69
5	Infections and course of disease in mild forms of Guillain–Barre syndrome Neurology ·Rinske van Koningsveld,P.I.M. Schmitz,C. Wim Ang,Jan Groen,Albert D. M. E. Osterhaus,F.G.A. van der Meché,Pieter A. van Doorn	2002	46
6	Diagnostic and Classification Criteria for the Guillain-Barré Syndrome European Neurology ·F.G.A. van der Meché,Pieter A. van Doorn,Jan Meulstee,F.G.I. Jennekens	2001	196
7	Serratus anterior paralysis as an occupational injury in scaffolders: Two case reports American Journal of Industrial Medicine ·L. A. M. Elders,F.G.A. van der Meché,Alex Burdorf	2001	10
8	Guillain-Barre Syndrome- and Miller Fisher Syndrome-Associated Campylobacter jejuni Lipopolysaccharides Induce Anti-GM ₁ and Anti-GQ _1b Antibodies in Rabbits Infection and Immunity ·C. Wim Ang,M. A. de Klerk,Hubert P. Endtz,Bart C. Jacobs,Jon D. Laman,F.G.A. van der Meché,Pieter A. van Doorn	2001	76
9	Management of acute inflammatory polyneuropathy (Guillain-Barré syndrome) European Journal of Anaesthesiology ·F.G.A. van der Meché	1998	2
10	Future Developments in the Treatment of Immune-Mediated Polyneuropathies European Neurology ·F.G.A. van der Meché,P.A. van Doorn	1997	11
11	Uvulopalatopharyngoplasty for the obstructive sleep apnoea syndrome: value of polysomnography, Mueller manoeuvre and cephalometry in predicting surgical outcome Clinical Otolaryngology ·S Zanoli,R. M. L. Poublon,G Ia Anishchenko,J. M. Bogaard,P.I.M. Schmitz,A. Z. Ginai,F.G.A. van der Meché	1997	21
12	Guillain‐Barré Syndrome: Multifactorial Mechanisms versus Defined Subgroups The Journal of Infectious Diseases ·F.G.A. van der Meché,L. H. Visser,Bart C. Jacobs,Hubert P. Endtz,Jan Meulstee,Pieter A. van Doorn	1997	42
13	Cross-Reactive Antibodies against Gangliosides and Campylobacter jejuni Lipopolysaccharides in Patients with Guillaln-Barre or Miller Fisher Syndrome The Journal of Infectious Diseases ·Bart C. Jacobs,M. P. Hazenberg,Pieter A. van Doorn,Hubert P. Endtz,F.G.A. van der Meché	1997	63
14	Cytomegalovirus infection and Guillain-Barre syndrome Neurology ·L. H. Visser,浅野晶子,F.G.A. van der Meché	1997	3
15	Guillain-Barré Syndrome Clinical Immunotherapeutics ·Pieter A. van Doorn,F.G.A. van der Meché	1994	1
16	Cardiac surgery and the brain Clinical Neurology and Neurosurgery ·F.G.A. van der Meché	1993	12
17	Upside down Guillain Barré syndrome Clinical Neurology and Neurosurgery ·J.P. ter Bruggen,F.G.A. van der Meché,A.E.J. de Jager,C. H. Polman,John H. J. Wokke	1991	2
18	Treatment of Guillain‐Barre syndrome with high‐dose gammaglobulin Neurology ·R. P. Kleyweg,F.G.A. van der Meché,Jan Meulstee	1988	178
19	Experiences with Guillain-Barré syndrome in a pediatric intensive care unit Intensive Care Medicine ·A. P. Bos,F.G.A. van der Meché,Maarten Witsenburg,E. van der Voort	1987	12
20	Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy Journal of the Neurological Sciences ·M. Vermeulen,F.G.A. van der Meché,Johannes D. Speelman,Alexander N.R. Weber,H. F. M. Busch	1985	136

About F.G.A. van der Meché

F.G.A. van der Meché is a scholar working on Neurology, Cellular and Molecular Neuroscience and Developmental Neuroscience, having authored 27 papers that have together received 1.6k indexed citations. Recurring topics across this work include Peripheral Neuropathies and Disorders (21 papers), Hereditary Neurological Disorders (12 papers), Long-Term Effects of COVID-19 (4 papers), Nerve injury and regeneration (3 papers), Autoimmune Neurological Disorders and Treatments (2 papers), Takotsubo Cardiomyopathy and Associated Phenomena (2 papers), Pain Mechanisms and Treatments (2 papers) and Multiple Sclerosis Research Studies (2 papers). The work is most often cited by research in Neurology (888 citations), Cellular and Molecular Neuroscience (586 citations) and Pathology and Forensic Medicine (463 citations). F.G.A. van der Meché has collaborated with scholars based in Netherlands, Slovakia and Germany. Frequent co-authors include Jan Meulstee, P.A. van Doorn, Rogier Q. Hintzen, R. P. Kleyweg, Pieter A. van Doorn, Pieter A. van Doorn, F.G.I. Jennekens, A. Cecile J.W. Janssens, Josien B. de Boer and Jan Passchier. Their work appears in journals such as Neurology, Clinical Neurology and Neurosurgery, The Journal of Infectious Diseases, American Journal of Industrial Medicine and Infection and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact